Abiraterone Acetate API (154229‑18‑2)

Name of Product	Abiraterone Acetate API
CAS No	154229‑18‑2
Therapeutic use:-	Androgen biosynthesis inhibitor (CYP17A1); used in prostate cancer
Grade	IP/USP
Form:-	API Powder
Status	Regular

INQUIRE ABOUT Abiraterone Acetate API (154229‑18‑2)

INQUIRE ABOUT Abiraterone Acetate API (154229‑18‑2)

Inquiry in product detail page

Subscribe

We are a 100% export-oriented company and do not engage in domestic sales within India.

Product Title

Name

Email

Phone

Country

SelectAfghanistanAland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelauBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Saint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicDemocratic Republic of the Congo (Kinshasa)DenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyIvory CoastJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRepublic of the Congo (Brazzaville)ReunionRomaniaRussiaRwandaSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Martin (Dutch part)Saint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia/Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited Kingdom (UK)United States (US)United States (US) Minor Outlying IslandsUnited States (US) Virgin IslandsUruguayUzbekistanVanuatuVaticanVenezuelaVietnamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Your Message

Submit

Product Overview

Abiraterone Acetate is a powerful and selective androgen biosynthesis inhibitor prescribed in the treatment of prostate cancer. It is a prodrug of abiraterone. This medicine blocks CYP17A1, which is an important enzyme that makes androgens. Abiraterone acetate makes testosterone levels go down. It does this by stopping the testes, adrenal glands, and tumors from making androgens. This helps keep prostate cancer cells from growing too quickly. You take it by mouth. It is often administered with corticosteroids to fix the hormonal imbalance it produces.

There are strong quality controls in place for this API (Active Pharmaceutical Ingredient). This makes sure that it is pure, works, and stays the same.

Therapeutic Applications

Abiraterone Acetate is a drug that helps fight cancer in hormone therapy. It is mainly used for:

Metastatic castration-resistant prostate cancer (mCRPC)

Metastatic high-risk castration-sensitive prostate cancer (mCSPC)

The chances of survival with advanced prostate cancer have increased.

Specification Parameters

Our Abiraterone Acetate meets all the parameters, including:

Looks: A white to off-white crystalline powder

Chemical Formula: C₂₆H₃₃NO₂

Molecular weight: 391.55g/mol

Assay (HPLC): ≥ 98.0%

Melting point: It is between 143 and 146 degrees Celsius.

Solubility: Practically insoluble in water in water; can dissolve in organic solvents.

Packaging & Storage

Double polyethylene bags are the main Packaging.

Secondary Packaging is a fiber drum or HDPE drum with an aluminum lining

Keep at a controlled room temperature (2–8°C is best for long-term stability).

Protect from heat, dampness, and sunshine.

When not using the solution, make sure the container is closed.

Proper packing keeps the product safe while it’s being shipped and makes it last longer on the shelf.

Why Choose Us

Manufacturing that meets GMP standards at cutting-edge facilities

High purity and quality that is always the same, satisfying global pharmacopeia criteria

Personalized help with paperwork (DMF, COA, MSDS, Stability Data)

Good regulatory support for approvals in the global market

Packaging that can be changed to fit the needs of each consumer and country

On-time delivery around the world, with help with logistics and cold chain management if needed

A dedicated R&D team to help with formulation compatibility and scaling up

In the worldwide pharmaceutical supply chain, we are committed to giving our partners APIs that are reliable, high-quality, and affordable.